UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 32

Sortiert nach

Third BNT162b2 Vaccination Neutralization of SARS-CoV-2 Omicron Infection

The New England journal of medicine, 2022-02, Vol.386 (5), p.492-494

2022

Volltextzugriff (PDF)

Efficacy of a Fourth Dose of Covid-19 mRNA Vaccine against Omicron

The New England journal of medicine, 2022-04, Vol.386 (14), p.1377-1380

2022

Volltextzugriff (PDF)

Genome-wide CRISPR screens identify GATA6 as a proviral host factor for SARS-CoV-2 via modulation of ACE2

Nature communications, 2022-04, Vol.13 (1), p.2237-2237, Article 2237

2022

Volltextzugriff (PDF)

Early Immunogenicity and Safety of the Third Dose of BNT162b2 Messenger RNA Coronavirus Disease 2019 Vaccine Among Adults Older Than 60 Years: Real-World Experience

The Journal of infectious diseases, 2022-03, Vol.225 (5), p.785-792

2022

Volltextzugriff (PDF)

The effect of ivermectin on the viral load and culture viability in early treatment of nonhospitalized patients with mild COVID-19 – a double-blind, randomized placebo-controlled trial

International journal of infectious diseases, 2022-09, Vol.122, p.733-740

2022

Volltextzugriff (PDF)

Influenza vaccine compatibility among hospitalized patients during and after the COVID-19 pandemic

Frontiers in microbiology, 2024-01, Vol.14, p.1296179-1296179

2024

Volltextzugriff (PDF)

Human metapneumovirus prevalence during 2019-2021 in Israel is influenced by the COVID-19 pandemic

International journal of infectious diseases, 2022-07, Vol.120, p.205-209

2022

Volltextzugriff (PDF)

Outbreak of Influenza and Other Respiratory Viruses in Hospitalized Patients Alongside the SARS-CoV-2 Pandemic

Frontiers in microbiology, 2022-06, Vol.13, p.902476-902476

2022

Volltextzugriff (PDF)

Viral co-pathogens in COVID-19 acute respiratory syndrome – what did we learn from the first year of pandemic?

International journal of infectious diseases, 2022-03, Vol.116, p.226-229

2022

Volltextzugriff (PDF)

Reduced Neutralization Efficacy against Omicron Variant after Third Boost of BNT162b2 Vaccine among Liver Transplant Recipients

Viruses, 2023-01, Vol.15 (1), p.253

2023

Volltextzugriff (PDF)

Immunogenicity of Co-Administered Omicron BA.4/BA.5 Bivalent COVID-19 and Quadrivalent Seasonal Influenza Vaccines in Israel during the 2022–2023 Winter Season

Vaccines (Basel), 2023-10, Vol.11 (10), p.1624

2023

Volltextzugriff (PDF)

The Rise and Fall of a Local SARS-CoV-2 Variant with the Spike Protein Mutation L452R

Vaccines (Basel), 2021-08, Vol.9 (8), p.937

2021

Volltextzugriff (PDF)

Diversity in the Circulation of Influenza A(H3N2) Viruses in the Northern Hemisphere in the 2018-19 Season

Vaccines (Basel), 2021-04, Vol.9 (4), p.375

2021

Volltextzugriff (PDF)

Predominance of a Drifted Influenza A (H3N2) Clade and its Association with Age-specific Influenza Vaccine Effectiveness Variations, Influenza Season 2018-2019

Vaccines (Basel), 2020-02, Vol.8 (1), p.78

2020

Volltextzugriff (PDF)

Neutralizing Response against Variants after SARS-CoV-2 Infection and One Dose of BNT162b2

The New England journal of medicine, 2021-06, Vol.384 (25), p.2453-2454

2021

Volltextzugriff (PDF)

Neutralising capacity against Delta (B.1.617.2) and other variants of concern following Comirnaty (BNT162b2, BioNTech/Pfizer) vaccination in health care workers, Israel

Euro surveillance : bulletin européen sur les maladies transmissibles, 2021-07, Vol.26 (26), p.1

2021

Volltextzugriff (PDF)

Fourth BNT162b2 Vaccination Neutralization of Omicron Infection after Heart Transplantation

The Journal of heart and lung transplantation, 2022-09, Vol.41 (9), p.1210-1213

2022

Volltextzugriff (PDF)

Is Now the Time for the Fourth BNT162b2 Dose for Residents of Long-term Care Facilities?

The journals of gerontology. Series A, Biological sciences and medical sciences, 2022-07, Vol.77 (7), p.1380-1381

2022

Volltextzugriff (PDF)

Epidemiological and clinical characteristics of hospitalized human metapneumovirus patients in Israel, 2015–2021: A retrospective cohort study

Journal of medical virology, 2024-06, Vol.96 (6), p.e29709-n/a

2024

Volltextzugriff (PDF)

STEP 1 for Effective Weight Control — Another First Step?

The New England journal of medicine, 2021-06, Vol.384 (25), p.2454-2454

2021

Volltextzugriff (PDF)

COVID-19 vaccination and BA.1 breakthrough infection induce neutralising antibodies which are less efficient against BA.4 and BA.5 Omicron variants, Israel, March to June 2022

Euro surveillance : bulletin européen sur les maladies transmissibles, 2022-07, Vol.27 (30), p.1

2022

Volltextzugriff (PDF)

Cocirculation of A(H3N2) and B/Victoria increased morbidity in hospitalized patients in the 2019–2020 A(H1N1)pdm09 predominant influenza season in Israel

Journal of medical virology, 2023-02, Vol.95 (2), p.e28498-n/a

2023

Volltextzugriff (PDF)

Sixth monovalent XBB.1.5 vaccine elicits robust immune response against emerging SARS-CoV-2 variants in heart transplant recipients

The Journal of heart and lung transplantation, 2024-07, Vol.43 (7), p.1188-1192

2024

Volltextzugriff (PDF)

Kinetics of cellular and humoral responses to third BNT162B2 COVID-19 vaccine over six months in heart transplant recipients – implications for the omicron variant

The Journal of heart and lung transplantation, 2022-10, Vol.41 (10), p.1417-1425

2022

Volltextzugriff (PDF)

Reduced neutralization efficacy against SARS-CoV-2 Omicron variant after third boost of mRNA BNT162 vaccine among liver transplant recipients

Journal of hepatology, 2022-07, Vol.77, p.S804-S805

2022

Volltextzugriff (PDF)

1 – 25 von 32

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(32)
Mit Volltextzugriff
(32)

Publikationsform

Artikel
(32)

Sprache

Englisch
(32)
Japanisch
(3)

Erscheinungsjahr

n.n

Thema

Science & Technology
(27)
Life Sciences & Biomedicine
(26)
Humans
(14)
Covid-19
(13)
Sars-Cov-2
(13)
Severe Acute Respiratory Syndrome Coronavirus 2
(12)
Vaccines
(10)
Infectious Diseases
(8)
Covid-19 Vaccines
(7)
Antibodies
(6)
Coronaviruses
(6)
Covid-19 - Prevention & Control
(6)
Immunology
(6)
Infections
(6)
Medical Personnel
(6)
Immunization
(5)
Pandemics
(5)
Adult
(4)
Aged
(4)
Covid-19 - Epidemiology
(4)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Third BNT162b2 Vaccination Neutralization of SARS-CoV-2 Omicron Infection

Efficacy of a Fourth Dose of Covid-19 mRNA Vaccine against Omicron

Genome-wide CRISPR screens identify GATA6 as a proviral host factor for SARS-CoV-2 via modulation of ACE2

Early Immunogenicity and Safety of the Third Dose of BNT162b2 Messenger RNA Coronavirus Disease 2019 Vaccine Among Adults Older Than 60 Years: Real-World Experience

The effect of ivermectin on the viral load and culture viability in early treatment of nonhospitalized patients with mild COVID-19 – a double-blind, randomized placebo-controlled trial

Influenza vaccine compatibility among hospitalized patients during and after the COVID-19 pandemic

Human metapneumovirus prevalence during 2019-2021 in Israel is influenced by the COVID-19 pandemic

Outbreak of Influenza and Other Respiratory Viruses in Hospitalized Patients Alongside the SARS-CoV-2 Pandemic

Viral co-pathogens in COVID-19 acute respiratory syndrome – what did we learn from the first year of pandemic?

Reduced Neutralization Efficacy against Omicron Variant after Third Boost of BNT162b2 Vaccine among Liver Transplant Recipients

Immunogenicity of Co-Administered Omicron BA.4/BA.5 Bivalent COVID-19 and Quadrivalent Seasonal Influenza Vaccines in Israel during the 2022–2023 Winter Season

The Rise and Fall of a Local SARS-CoV-2 Variant with the Spike Protein Mutation L452R

Diversity in the Circulation of Influenza A(H3N2) Viruses in the Northern Hemisphere in the 2018-19 Season

Predominance of a Drifted Influenza A (H3N2) Clade and its Association with Age-specific Influenza Vaccine Effectiveness Variations, Influenza Season 2018-2019

Neutralizing Response against Variants after SARS-CoV-2 Infection and One Dose of BNT162b2

Neutralising capacity against Delta (B.1.617.2) and other variants of concern following Comirnaty (BNT162b2, BioNTech/Pfizer) vaccination in health care workers, Israel

Fourth BNT162b2 Vaccination Neutralization of Omicron Infection after Heart Transplantation

Is Now the Time for the Fourth BNT162b2 Dose for Residents of Long-term Care Facilities?

Epidemiological and clinical characteristics of hospitalized human metapneumovirus patients in Israel, 2015–2021: A retrospective cohort study

STEP 1 for Effective Weight Control — Another First Step?

COVID-19 vaccination and BA.1 breakthrough infection induce neutralising antibodies which are less efficient against BA.4 and BA.5 Omicron variants, Israel, March to June 2022

Cocirculation of A(H3N2) and B/Victoria increased morbidity in hospitalized patients in the 2019–2020 A(H1N1)pdm09 predominant influenza season in Israel

Sixth monovalent XBB.1.5 vaccine elicits robust immune response against emerging SARS-CoV-2 variants in heart transplant recipients

Kinetics of cellular and humoral responses to third BNT162B2 COVID-19 vaccine over six months in heart transplant recipients – implications for the omicron variant

Reduced neutralization efficacy against SARS-CoV-2 Omicron variant after third boost of mRNA BNT162 vaccine among liver transplant recipients

Suchergebnisse filtern